Table 1 of
Yigit, Mol Vis 2013; 19:1626-1630. Table 1 of
Yigit, Mol Vis 2013; 19:1626-1630.
Table 1. Baseline clinical and demographical features of the 230 study patients with DPN.
| Characteristic | Total n=230 | CC n=123 | CT n=85 | TT n=22 | P value |
|---|---|---|---|---|---|
| Gender, no. male/female (%) | 61/169 (26.5/73.5) | 32/91 (26.0/74.0) | 24/61 (28.2/71.8) | 5/17 (22.7/77.3) | 0.858 |
| Age (years) | 57.15±10.580 | 57.46±11.440 | 56.21±9.912 | 59.09±7.708 | 0.472 |
| Disease duration (years) | 7.73±6.006 | 7.13±6.015 | 8.38±6.184 | 8.55±5.078 | 0.271 |
| Height (cm) | 162.84±6.753 | 162.61±6.807 | 163.82±6.973 | 160.00±4.410 | 0.073 |
| Weight (kg) | 78.53±9.208 | 78.42±9.684 | 78.16±8.941 | 80.74±7.504 | 0.540 |
| BMI (kg/m2) | 29.78±4.260 | 29.81±4.562 | 29.24±3.888 | 31.66±3.402 | 0.059 |
| Hemoglobin (g/dl) | 12.91±1.241 | 12.85±1.229 | 12.95±1.290 | 13.02±1.154 | 0.766 |
| Serum creatinine (mg/dl) | 0.80±0.232 | 0.79±0.239 | 0.82±0.238 | 0.75±0.145 | 0.332 |
| HbA1C (%) | 6.97±1.668 | 7.04±1.891 | 7.04±1.442 | 6.29±0.839 | 0.128 |
| Triglyceride (mg/dl) | 166.44±80.057 | 160.29±54.746 | 179.25±110.787 | 151.36±47.530 | 0.159 |
| Total cholesterol (mg/dl) | 187.34±53.062 | 185.45±45.675 | 189.53±63.832 | 189.45±47.333 | 0.847 |
| HDL cholesterol (mg/dl) | 41.57±9.820 | 41.64±10.061 | 40.76±9.171 | 44.23±10.819 | 0.336 |
| LDL cholesterol (mg/dl) | 129.57±32.376 | 128.44±32.108 | 131.24±32.439 | 129.40±34.827 | 0.829 |
| Systolic blood pressure (mmHg) | 129.53±22.336 | 127.95±21.137 | 131.41±23.787 | 131.14±23.449 | 0.516 |
| Diastolic blood pressure (mmHg) | 81.10±14.550 | 80.15±14.718 | 82.47±14.467 | 81.14±14.136 | 0.529 |
| Type of diabetes mellitus, no. Type 1/Type 2 (%) | 5/225 (2.2/97.8) | 3/120 (2.4/97.6) | 2/83 (2.4/97.6) | 0/22 (0/100) | 0.762 |
| History of retinopathy, no. Positive/Negative (%) | 81/149 (35.2/64.8) | 38/85 (30.9/69.1) | 30/55 (35.3/64.7) | 13/9 (59.1/40.9) | 0.039 |
| History of hypertension, no. (%) | 129 (56.1) | 65 (50.4) | 50 (38.8) | 14 (10.95) | 0.524 |
| Medications, no. Oral antidiabetic/Insulin (%) | 177/38 (77.0/16.5) | 91/23 (74.0/18.7) | 65/15 (76.5/17.6) | 21/0 (95.5/0) | 0.242 |
| Smoking, no. (%) | 30 (13.1) | 15 (50.0) | 12 (40.0) | 3 (10.0) | 0.906 |